cuprous chloride has been researched along with malondialdehyde in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, TW; Jacobi, H; Krieger, G; Vöhringer, ML; Witte, I | 1 |
| Chan, EK; Chan, JK; Cheung, JC; Cheung, JP; Siu, AW; To, CH | 1 |
| Duriez, P; Fruchart, JC; Glowacki, F; Kandoussi, AM; Noël, C; Tacquet, A | 1 |
3 other study(ies) available for cuprous chloride and malondialdehyde
| Article | Year |
|---|---|
Synergistic DNA damaging effects of malondialdehyde/Cu(II) in PM2 DNA and in human fibroblasts.
Topics: Administration, Topical; Anti-Inflammatory Agents; Bacteriophages; Cell Survival; Cells, Cultured; Chelating Agents; Copper; Dimethyl Sulfoxide; DNA Damage; DNA, Single-Stranded; DNA, Viral; Drug Synergism; Fibroblasts; Humans; Malondialdehyde; Phenanthrolines | 1998 |
N-acetyl-serotonin reduces copper (I) ion-induced lipid peroxidation in bovine retinal homogenates.
Topics: Animals; Antioxidants; Cattle; Copper; Dose-Response Relationship, Drug; Lipid Peroxidation; Lipid Peroxides; Malondialdehyde; Oxidative Stress; Retina; Serotonin; Vitamin E | 2001 |
Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients.
Topics: Autoantibodies; Copper; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lipids; Lipoproteins, LDL; Longitudinal Studies; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Renal Dialysis; Transplantation Immunology | 2001 |